—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Laboratorios Farmaceuticos ROVI (ROVI.MC) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 62 out of 100 (momentum 46 · quality 77 · valuation 48), as of 2026-11-03.
  • Signal: Recovery attempt under the 200-day — Trades +6.9% vs the 50-day and -3.1% vs the 200-day average, 25.7% below the 52-week high and +19.7% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Laboratorios Farmaceuticos ROVI trades 6.9% above its 50-day and 3.1% below its 200-day moving average. (as of 2026-11-02)

Rovi makes and sells pharmaceutical products across Spain, the EU and other OECD markets, spanning prescription medicines, hospital products such as contrast agents and catheter-care lines, and contract-manufacturing services for injectable drugs including prefilled syringes and vials. It also develops its own molecules, including a low-molecular-weight heparin and newer central-nervous-system treatments.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ROVI.MC overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +6.9% vs the 50-day and -3.1% vs the 200-day average, 25.7% below the 52-week high and +19.7% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ROVI.MC chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on ROVI.MC?

Recovery attempt under the 200-day — Trades +6.9% vs the 50-day and -3.1% vs the 200-day average, 25.7% below the 52-week high and +19.7% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ROVI.MC above its 50-day and 200-day moving averages?

As of 2026-11-02, Laboratorios Farmaceuticos ROVI trades +6.9% above its 50-day and -3.1% below its 200-day average, with the 20-day +6.3% away.

How far is ROVI.MC from its 52-week high?

25.7% below the 52-week high and 19.7% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.